首页 > 最新文献

Arhiv za Farmaciju最新文献

英文 中文
Established and advanced adjuvants in vaccines' formulation: Mineral adsorbents, nanoparticulate carriers and microneedle delivery systems 疫苗配方中已建立和先进的佐剂:矿物吸附剂、纳米颗粒载体和微针递送系统
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/arhfarm1906420k
D. Krajišnik, T. Ilić, I. Nikolić, S. Savić
In the era of modern vaccinology, limited immunogenicity of the most commonly used antigens has enforced the use of various adjuvants in vaccine formulations to achieve desired immune response. Aluminum-containing adjuvants have been, historically, the most widely used mineral immunostimulants, generally regarded as safe to use in human vaccines. The great academic progress in inorganic (nano)materials synthesis, structure control and functionalization design has led to a growing interest in innovative adjuvants such as clays, mesoporous silica nanoparticles, zinc oxide, iron oxide and iron hydroxide nanoparticles, etc. On the other hand, there has been an intention to use specific nanoparticulated antigen delivery systems, such as nanoemulsions, in order to protect antigens from premature proteolytic degradation and/or to improve antigen immunogenicity by facilitating antigen uptake and processing by antigen presenting cells. Simultaneously, numerous research efforts have been focused on the development of innovative technologies for antigen delivery into the skin (such as microneedles), with the aim to improve vaccine efficacy alongside with enhanced patient adherence, particularly in children population (noninvasive or minimally invasive administration). Therefore, this review deals with each of these approaches in more detail, with the special emphasis on examples of their use in vaccine formulations as well as on the factors influencing their efficacy and safety.
在现代疫苗学时代,最常用抗原的有限免疫原性迫使在疫苗配方中使用各种佐剂以达到预期的免疫反应。从历史上看,含铝佐剂是使用最广泛的矿物免疫刺激剂,通常被认为可以安全用于人类疫苗。无机(纳米)材料合成、结构控制和功能化设计方面的巨大学术进展,导致人们对粘土、介孔二氧化硅纳米颗粒、氧化锌、氧化铁和氢氧化铁纳米颗粒等创新助剂的兴趣日益浓厚。另一方面,有一种意图是使用特定的纳米关节抗原递送系统,如纳米乳液,以保护抗原免受过早的蛋白水解降解和/或通过促进抗原被抗原呈递细胞摄取和加工来提高抗原的免疫原性。同时,许多研究工作都集中在开发抗原注入皮肤的创新技术(如微针)上,目的是提高疫苗效力,同时增强患者的依从性,特别是在儿童群体中(无创或微创给药)。因此,本综述将更详细地讨论每一种方法,并特别强调它们在疫苗制剂中的应用实例以及影响其有效性和安全性的因素。
{"title":"Established and advanced adjuvants in vaccines' formulation: Mineral adsorbents, nanoparticulate carriers and microneedle delivery systems","authors":"D. Krajišnik, T. Ilić, I. Nikolić, S. Savić","doi":"10.5937/arhfarm1906420k","DOIUrl":"https://doi.org/10.5937/arhfarm1906420k","url":null,"abstract":"In the era of modern vaccinology, limited immunogenicity of the most commonly used antigens has enforced the use of various adjuvants in vaccine formulations to achieve desired immune response. Aluminum-containing adjuvants have been, historically, the most widely used mineral immunostimulants, generally regarded as safe to use in human vaccines. The great academic progress in inorganic (nano)materials synthesis, structure control and functionalization design has led to a growing interest in innovative adjuvants such as clays, mesoporous silica nanoparticles, zinc oxide, iron oxide and iron hydroxide nanoparticles, etc. On the other hand, there has been an intention to use specific nanoparticulated antigen delivery systems, such as nanoemulsions, in order to protect antigens from premature proteolytic degradation and/or to improve antigen immunogenicity by facilitating antigen uptake and processing by antigen presenting cells. Simultaneously, numerous research efforts have been focused on the development of innovative technologies for antigen delivery into the skin (such as microneedles), with the aim to improve vaccine efficacy alongside with enhanced patient adherence, particularly in children population (noninvasive or minimally invasive administration). Therefore, this review deals with each of these approaches in more detail, with the special emphasis on examples of their use in vaccine formulations as well as on the factors influencing their efficacy and safety.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The potential of Corona Charged Aerosol Detector for investigation of telmisartan: B-cyclodextrin inclusion complexes 电晕带电气溶胶检测器用于研究替米沙坦:b -环糊精包合物的潜力
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/arhfarm1901001m
Nevena Maljurić, Jelena Golubović, Biljana Otašević, Jovana Krmar, M. Zečević, A. Protić
Cyclodextrins (CDs) are widely used in pharmaceutical analysis due to its biodegradability and eco-friendly character. The particular structure of CDs, characterized by hydrophobic cavity, enables the formation of inclusion complexes with variety of organic compounds. As structures lacking chromophores, CDs could not be detected by Photodiode Array (PDA) detector and Corona Charged Aerosol Detector (CAD) was introduced as the most appropriate detector for the formed complexes. The aim of the study was to investigate the degree of complexation between telmisartan, used as a model substance, and β-CD. Moreover, the effect of different β-CD concentrations (5-15 mM) and pH of the aqueous part of mobile phase (3-7) on the degree of complexation was also assessed. The intensity of the formed complex appeared to be the highest when 15 mM β-CD was used for the complexation. Also, it was noticed that the increase in peak areas with an increasing β-CD concentration was more evident at pH 7 in comparison with the same trend at lower pH values. The reproducibility of the measurement was confirmed by low relative standard deviation (RSD) of peak areas within five measurements. These findings support the use of HPLC-CAD methods for studying the process of inclusion complexes formation.
环糊精具有生物可降解性和生态友好性,在药物分析中得到了广泛的应用。CDs具有疏水空腔的特殊结构,可与多种有机化合物形成包合物。由于缺乏发色团的结构,CDs无法通过光电二极管阵列(PDA)检测器检测到,因此引入了电晕带电气溶胶检测器(CAD)作为最合适的检测器来检测形成的配合物。该研究的目的是研究替米沙坦(作为模型物质)与β-CD之间的络合程度。此外,还考察了不同的β-CD浓度(5 ~ 15 mM)和流动相水相pH(3 ~ 7)对络合度的影响。用15mm β-CD络合时,形成的络合物强度最高。在pH为7时,随着β-CD浓度的增加,峰面积的增加更为明显,而在较低的pH值下,这一趋势也更为明显。在5次测量中,峰面积的相对标准偏差(RSD)较低,证实了测量的重复性。这些发现支持使用HPLC-CAD方法来研究包合物形成过程。
{"title":"The potential of Corona Charged Aerosol Detector for investigation of telmisartan: B-cyclodextrin inclusion complexes","authors":"Nevena Maljurić, Jelena Golubović, Biljana Otašević, Jovana Krmar, M. Zečević, A. Protić","doi":"10.5937/arhfarm1901001m","DOIUrl":"https://doi.org/10.5937/arhfarm1901001m","url":null,"abstract":"Cyclodextrins (CDs) are widely used in pharmaceutical analysis due to its biodegradability and eco-friendly character. The particular structure of CDs, characterized by hydrophobic cavity, enables the formation of inclusion complexes with variety of organic compounds. As structures lacking chromophores, CDs could not be detected by Photodiode Array (PDA) detector and Corona Charged Aerosol Detector (CAD) was introduced as the most appropriate detector for the formed complexes. The aim of the study was to investigate the degree of complexation between telmisartan, used as a model substance, and β-CD. Moreover, the effect of different β-CD concentrations (5-15 mM) and pH of the aqueous part of mobile phase (3-7) on the degree of complexation was also assessed. The intensity of the formed complex appeared to be the highest when 15 mM β-CD was used for the complexation. Also, it was noticed that the increase in peak areas with an increasing β-CD concentration was more evident at pH 7 in comparison with the same trend at lower pH values. The reproducibility of the measurement was confirmed by low relative standard deviation (RSD) of peak areas within five measurements. These findings support the use of HPLC-CAD methods for studying the process of inclusion complexes formation.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New vaccines on the horizon 新疫苗即将问世
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/arhfarm1906385a
N. Arsenović-Ranin
{"title":"New vaccines on the horizon","authors":"N. Arsenović-Ranin","doi":"10.5937/arhfarm1906385a","DOIUrl":"https://doi.org/10.5937/arhfarm1906385a","url":null,"abstract":"","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstructive sleep apnea and cardiometabolic risk 阻塞性睡眠呼吸暂停和心脏代谢风险
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/arhfarm1903153v
J. Vekić, Z. Jelić-Ivanović, A. Zeljković, A. Stefanović, V. Spasojević-Kalimanovska
{"title":"Obstructive sleep apnea and cardiometabolic risk","authors":"J. Vekić, Z. Jelić-Ivanović, A. Zeljković, A. Stefanović, V. Spasojević-Kalimanovska","doi":"10.5937/arhfarm1903153v","DOIUrl":"https://doi.org/10.5937/arhfarm1903153v","url":null,"abstract":"","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of magnesium sulfate in the treatment of acute postoperative pain 硫酸镁在急性术后疼痛治疗中的作用
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/arhfarm1905349v
S. Vučković, K. Savic-Vujovic, D. Srebro, Lepa Jovanović, M. Prostran
{"title":"Role of magnesium sulfate in the treatment of acute postoperative pain","authors":"S. Vučković, K. Savic-Vujovic, D. Srebro, Lepa Jovanović, M. Prostran","doi":"10.5937/arhfarm1905349v","DOIUrl":"https://doi.org/10.5937/arhfarm1905349v","url":null,"abstract":"","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of prophylactic vaccines in the elderly 预防疫苗在老年人中的应用
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/arhfarm1906469b
B. Bufan
Produženje ljudskog veka i povećanje broja starih (stariji od 65 godina) na svetskom nivou nosi sa sobom izazove za javno-zdravstveni sistem jer se radi o populaciji podložnoj infektivnim bolestima. Vakcinacija je jedan od načina prevencije ovih bolesti. U cilju poboljšanja kvaliteta života, smanjenja komplikacija bolesti, hospitalizacija i mortaliteta starih, mnoge evropske države i Sjedinjene Američke Države, kod starih osoba, preporučuju vakcinaciju protiv gripa, pneumokoka, varičela-zoster virusa (VZV), kao i „booster” vakcinacije protiv tetanusa, pertusisa i difterije. Razlog veće podložnosti infektivnim bolestima i manjoj efikasnosti vakcina kod starih su starenjem uslovljene promene koje pogađaju imunski sistem, a koje utiču na njegovu funkciju. Sezonska vakcina protiv gripa se u većini evropskih zemalja preporučuje starijima od 65 godina. Budući da je njena efikasnost niža kod starih nego kod odraslih osoba, razvijaju se strategije koje bi prevazišle ovaj problem (uključivanje adjuvansa u formulaciju, povećanje doze, promena puta unošenja antigena, razvoj vektorskih vakcina). Protiv pneumokoka su dostupne polisaharidna i konjugovana vakcina, a podaci o njihovoj efikasnosti su nekonzistentni. Vakcina protiv VZV je atenuisana, živa vakcina i pokazala se efikasna u smanjenju incidencije herpes zostera i post-herpetične neuralgije. Podizanje svesti o značaju vakcinacije starih osoba i razvoj vakcina prilagođenih ovoj populaciji su od velikog značaja za očuvanje njihovog zdravlja.
世界范围内人类年龄的延长和老年人(65岁以上)数量的增加对公共卫生系统构成了挑战,因为人口中有适当的传染病。疫苗是预防这些疾病的方法之一。为了提高生活质量,减少老年人的疾病并发症、住院和死亡率,许多欧洲国家和美利坚合众国的老年人建议接种流感、肺炎球菌、水痘-带状疱疹病毒疫苗,以及破伤风、百日咳和白喉加强针。感染性疾病和疫苗对老年人的有效性降低的更大原因是免疫系统影响的变化受到衰老的影响。季节性流感疫苗被推荐用于大多数65岁以上的欧洲国家。Budući da je njena efikasnost niža kod starih nego kod odraslih osoba,razvijaju se strategije koje bi prevazišle ovaj问题(uključivanje adjuvansa u formulaciju,povećanje doze,promena puta unošenja antigena,razvoj vektorskih vakcina)。对于肺炎球菌,多糖和结合疫苗是可用的,关于其有效性的数据是不相容的。针对VZV的疫苗是一种活疫苗,已被证明能有效降低带状疱疹和疱疹后神经痛的发病率。提高老年人对接种疫苗重要性的认识,并开发适合这一人群的疫苗,对保持他们的健康至关重要。
{"title":"Application of prophylactic vaccines in the elderly","authors":"B. Bufan","doi":"10.5937/arhfarm1906469b","DOIUrl":"https://doi.org/10.5937/arhfarm1906469b","url":null,"abstract":"Produženje ljudskog veka i povećanje broja starih (stariji od 65 godina) na svetskom nivou nosi sa sobom izazove za javno-zdravstveni sistem jer se radi o populaciji podložnoj infektivnim bolestima. Vakcinacija je jedan od načina prevencije ovih bolesti. U cilju poboljšanja kvaliteta života, smanjenja komplikacija bolesti, hospitalizacija i mortaliteta starih, mnoge evropske države i Sjedinjene Američke Države, kod starih osoba, preporučuju vakcinaciju protiv gripa, pneumokoka, varičela-zoster virusa (VZV), kao i „booster” vakcinacije protiv tetanusa, pertusisa i difterije. Razlog veće podložnosti infektivnim bolestima i manjoj efikasnosti vakcina kod starih su starenjem uslovljene promene koje pogađaju imunski sistem, a koje utiču na njegovu funkciju. Sezonska vakcina protiv gripa se u većini evropskih zemalja preporučuje starijima od 65 godina. Budući da je njena efikasnost niža kod starih nego kod odraslih osoba, razvijaju se strategije koje bi prevazišle ovaj problem (uključivanje adjuvansa u formulaciju, povećanje doze, promena puta unošenja antigena, razvoj vektorskih vakcina). Protiv pneumokoka su dostupne polisaharidna i konjugovana vakcina, a podaci o njihovoj efikasnosti su nekonzistentni. Vakcina protiv VZV je atenuisana, živa vakcina i pokazala se efikasna u smanjenju incidencije herpes zostera i post-herpetične neuralgije. Podizanje svesti o značaju vakcinacije starih osoba i razvoj vakcina prilagođenih ovoj populaciji su od velikog značaja za očuvanje njihovog zdravlja.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active immunotherapy of cancer: An overview of therapeutic vaccines 癌症的主动免疫治疗:治疗性疫苗综述
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/arhfarm1906490f
B. Filipic, Z. Stojić-Vukanić
{"title":"Active immunotherapy of cancer: An overview of therapeutic vaccines","authors":"B. Filipic, Z. Stojić-Vukanić","doi":"10.5937/arhfarm1906490f","DOIUrl":"https://doi.org/10.5937/arhfarm1906490f","url":null,"abstract":"","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacotherapy of the most frequent headaches in adults 成人最常见头痛的药物治疗
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/ARHFARM1806032Z
J. Zidverc-Trajkovic
{"title":"Pharmacotherapy of the most frequent headaches in adults","authors":"J. Zidverc-Trajkovic","doi":"10.5937/ARHFARM1806032Z","DOIUrl":"https://doi.org/10.5937/ARHFARM1806032Z","url":null,"abstract":"","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A personalized approach to assessing and managing pain in patients with cancer 一种评估和管理癌症患者疼痛的个性化方法
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/ARHFARM1806045D
J. Dimitrijevic
{"title":"A personalized approach to assessing and managing pain in patients with cancer","authors":"J. Dimitrijevic","doi":"10.5937/ARHFARM1806045D","DOIUrl":"https://doi.org/10.5937/ARHFARM1806045D","url":null,"abstract":"","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 45
Herbal medicinal products in the treatment of cough associated with colds 治疗感冒引起的咳嗽的草药产品
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01 DOI: 10.5937/arhfarm1904270k
T. Kundaković-Vasović, J. Radović
{"title":"Herbal medicinal products in the treatment of cough associated with colds","authors":"T. Kundaković-Vasović, J. Radović","doi":"10.5937/arhfarm1904270k","DOIUrl":"https://doi.org/10.5937/arhfarm1904270k","url":null,"abstract":"","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arhiv za Farmaciju
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1